However, at present, it has only been reported that chemotherapeutic drugs induced cell pyroptosis in lung cancer by the NF-κB pathway, ROS inducing, APE1 target as well as NLRP3 inflammasome52–55, and much remains unknown about the regulatory mechanisms. Here, NFKB1 is linked to lung carcinoma.